Previous Article | Next Article 
Journal of Virology, February 2004, p. 1981-1991, Vol. 78, No. 4
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.4.1981-1991.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Epstein-Barr Virus Nuclear Antigen 3C Regulates Cyclin A/p27 Complexes and Enhances Cyclin A-Dependent Kinase Activity
Jason S. Knight and Erle S. Robertson*
Department of Microbiology and Abramson Comprehensive Cancer Center, University of Pennsylvania Medical School, Philadelphia, Pennsylvania 19104
Received 3 September 2003/
Accepted 29 October 2003
Epstein-Barr virus (EBV) nuclear antigen 3C (EBNA3C) is essential for primary B-cell transformation. In this report we show that cyclin A, an activator of S phase progression, bound tightly to EBNA3C. EBNA3C interacted with cyclin A in vitro and associated with cyclin A complexes in EBV-transformed lymphoblastoid cell lines. Importantly, EBNA3C stimulated cyclin A-dependent kinase activity and rescued p27-mediated inhibition of cyclin A/Cdk2 kinase activity by decreasing the molecular association between cyclin A and p27 in cells. Additionally, phosphorylation of the retinoblastoma protein, a major regulator of cell cycle progression, was enhanced both in vitro and in vivo in the presence of EBNA3C. Cyclin A interacted with a region of the carboxy terminus of EBNA3C, shown to be important both for stimulation of cyclin A-dependent kinase activity and for cell cycle progression. This provides the first evidence of an essential EBV latent antigen's directly targeting a cell cycle regulatory protein and suggests a novel mechanism by which EBV deregulates the mammalian cell cycle, which is of critical importance in B-cell transformation.
* Corresponding author. Mailing address: Department of Microbiology and Abramson Comprehensive Cancer Center, University of Pennsylvania Medical School, 201 E Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104. Phone: (215) 746-0114. Fax: (215) 898-9557. E-mail:
erle{at}mail.med.upenn.edu.
Journal of Virology, February 2004, p. 1981-1991, Vol. 78, No. 4
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.4.1981-1991.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Everly, D. N. Jr., Mainou, B. A., Raab-Traub, N.
(2009). Transcriptional Downregulation of p27KIP1 through Regulation of E2F Function during LMP1-Mediated Transformation. J. Virol.
83: 12671-12679
[Abstract]
[Full Text]
-
Saha, A., Murakami, M., Kumar, P., Bajaj, B., Sims, K., Robertson, E. S.
(2009). Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2. J. Virol.
83: 4652-4669
[Abstract]
[Full Text]
-
Maruo, S., Wu, Y., Ito, T., Kanda, T., Kieff, E. D., Takada, K.
(2009). Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Proc. Natl. Acad. Sci. USA
106: 4419-4424
[Abstract]
[Full Text]
-
Bajaj, B. G., Murakami, M., Cai, Q., Verma, S. C., Lan, K., Robertson, E. S.
(2008). Epstein-Barr Virus Nuclear Antigen 3C Interacts with and Enhances the Stability of the c-Myc Oncoprotein. J. Virol.
82: 4082-4090
[Abstract]
[Full Text]
-
Kashuba, E., Yurchenko, M., Yenamandra, S. P., Snopok, B., Isaguliants, M., Szekely, L., Klein, G.
(2008). EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes. Proc. Natl. Acad. Sci. USA
105: 5489-5494
[Abstract]
[Full Text]
-
Choudhuri, T., Verma, S. C., Lan, K., Murakami, M., Robertson, E. S.
(2007). The ATM/ATR Signaling Effector Chk2 Is Targeted by Epstein-Barr Virus Nuclear Antigen 3C To Release the G2/M Cell Cycle Block. J. Virol.
81: 6718-6730
[Abstract]
[Full Text]
-
Munoz-Fontela, C., Garcia, M. A., Collado, M., Marcos-Villar, L., Gallego, P., Esteban, M., Rivas, C.
(2007). Control of virus infection by tumour suppressors. Carcinogenesis
28: 1140-1144
[Abstract]
[Full Text]
-
Maruo, S., Wu, Y., Ishikawa, S., Kanda, T., Iwakiri, D., Takada, K.
(2006). Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Proc. Natl. Acad. Sci. USA
103: 19500-19505
[Abstract]
[Full Text]
-
Jimenez-Ramirez, C., Brooks, A. J., Forshell, L. P., Yakimchuk, K., Zhao, B., Fulgham, T. Z., Sample, C. E.
(2006). Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter. J. Virol.
80: 11200-11208
[Abstract]
[Full Text]
-
Knight, J. S., Sharma, N., Robertson, E. S.
(2005). Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc. Natl. Acad. Sci. USA
102: 18562-18566
[Abstract]
[Full Text]
-
Knight, J. S., Sharma, N., Robertson, E. S.
(2005). SCFSkp2 Complex Targeted by Epstein-Barr Virus Essential Nuclear Antigen. Mol. Cell. Biol.
25: 1749-1763
[Abstract]
[Full Text]
-
Everly, D. N. Jr., Mainou, B. A., Raab-Traub, N.
(2004). Induction of Id1 and Id3 by Latent Membrane Protein 1 of Epstein-Barr Virus and Regulation of p27/Kip and Cyclin-Dependent Kinase 2 in Rodent Fibroblast Transformation. J. Virol.
78: 13470-13478
[Abstract]
[Full Text]
-
Knight, J. S., Sharma, N., Kalman, D. E., Robertson, E. S.
(2004). A Cyclin-Binding Motif within the Amino-Terminal Homology Domain of EBNA3C Binds Cyclin A and Modulates Cyclin A-Dependent Kinase Activity in Epstein-Barr Virus-Infected Cells. J. Virol.
78: 12857-12867
[Abstract]
[Full Text]